The AI tool, which Jvion brands as its “cognitive clinical success machine” solution, will help Geisinger Medical Center reduce avoidable readmissions related to chronic obstructive pulmonary disease, a group of lung diseases.
Geisinger’s Steele Institute for Healthcare Innovation opted to deploy Jvion’s solution at Geisinger Medical Center following a successful pilot at the health system.
“Leveraging demonstrated AI, we hope to accelerate our path to preventing patient illness and deterioration, optimizing patient care, and improving patient health outcomes,” Karen Murphy, RN, PhD, executive vice president, chief innovation officer and founding director of Geisinger’s Steele Institute for Healthcare Innovation said in Jvion’s July 3 statement.
More articles on artificial intelligence:
Northwestern Medicine to establish AI cardiovascular program with $25M gift
Canadian university collaborates with Google to use AI, radars to help diabetes patients
U of Iowa Health Care 1st to adopt landmark FDA-approved AI device in diabetes setting
